Literature DB >> 3001080

Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms.

E B McGowan, T C Detwiler.   

Abstract

The normally quick response of platelets to alpha-thrombin is delayed under two conditions. After pretreatment of platelets with chymotrypsin or certain other proteases, aggregation and secretion induced by alpha-thrombin begins after a delay of 30 s or more compared to less than 5 s for control platelets, and control platelets are activated by gamma-thrombin with a similar delay (Tam, S. W., Fenton, J. W., II, and Detwiler, T. C. (1980) J. Biol. Chem. 255, 6626-6632). Under these conditions, thrombin-induced inhibition of adenylate cyclase was blocked. The impaired regulation of adenylate cyclase and delayed secretion had in common: (i) partial correction with high concentrations of thrombin; (ii) similar thrombin dose-response relationships; (iii) similar concentration dependence for chymotrypsin during pretreatment; and (iv) specificity for thrombin. Other parameters of thrombin-induced platelet activation were also analyzed under these conditions. Thrombin-induced hydrolysis of arachidonyl esters and synthesis of prostanoids were similar to regulation of adenylate cyclase; they were blocked, with partial correction at high concentrations of thrombin. In contrast, thrombin-induced synthesis of phosphatidic acid and phosphorylation of a 20- and a 40-kDa protein were similar to secretion; they occurred after a delay but to a normal extent. The thrombin-induced increase in cytosolic calcium ion activity was slightly slower in chymotrypsin-treated platelets or in response to gamma-thrombin, but it was complete prior to initiation of the delayed responses. It is concluded that platelets have at least two types of thrombin receptors or coupling mechanisms, one of which is sensitive to chymotrypsin, unresponsive to gamma-thrombin, and coupled to inhibition of adenylate cyclase and activation of prostanoid synthesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001080

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Thrombin, unlike vasopressin, appears to stimulate two distinct guanine nucleotide regulatory proteins in human platelets.

Authors:  M D Houslay; D Bojanic; D Gawler; S O'Hagan; A Wilson
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

2.  Effects of separate proteolytic and high-affinity binding activities of human thrombin on rapid platelet activation. A quenched-flow study.

Authors:  G D Jones; D J Carty; D L Freas; J T Spears; A R Gear
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

3.  Thrombin exerts a dual effect on stimulated adenylate cyclase in hamster fibroblasts, an inhibition via a GTP-binding protein and a potentiation via activation of protein kinase C.

Authors:  I Magnaldo; J Pouysségur; S Paris
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

4.  Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.

Authors:  K A Williams; W Murphy; R J Haslam
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

5.  The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation.

Authors:  W F Bahou; B S Coller; C L Potter; K J Norton; J L Kutok; M S Goligorsky
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Thrombin-induced phosphoinositide hydrolysis in platelets. Receptor occupancy and desensitization.

Authors:  E M Huang; T C Detwiler
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

7.  Multiphasic generation of diacylglycerol in thrombin-activated human platelets.

Authors:  M H Werner; A E Bielawska; Y A Hannun
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

8.  Regulation of platelet glycoprotein IIb/IIIa (integrin alpha IIB beta 3) function via the thrombin receptor.

Authors:  A N Giesberts; G van Willigen; E G Lapetina; J W Akkerman
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

9.  Thrombin inhibits the pertussis-toxin-dependent ADP-ribosylation of a novel soluble Gi-protein in human platelets.

Authors:  J M Gennity; W Siess
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

10.  G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor-mediated stimuli.

Authors:  C Brom; J Brom; W König
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.